Integra LifeSciences Holdings Corporation (IART)
-NasdaqGS 35.00 
0.38(1.10%) 4:00PM EDT|After Hours
:
35.00 0.00 (0.00%) 4:27PM EDT
| Prev Close: | 34.62 |
|---|
| Open: | 36.53 |
|---|
| Bid: | 31.74 x 600 |
|---|
| Ask: | 36.31 x 100 |
|---|
| 1y Target Est: | 41.55 |
|---|
| Beta: | 0.91 |
|---|
| Next Earnings Date: | 2-May-13 |
|---|
| Day's Range: | 33.13 - 39.00 |
|---|
| 52wk Range: | 30.87 - 44.53 |
|---|
| Volume: | 461,456 |
|---|
| Avg Vol (3m): | 205,962 |
|---|
| Market Cap: | 979.62M |
|---|
| P/E (ttm): | 24.31 |
|---|
| EPS (ttm): | 1.44 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Integra LifeSciences Holdings Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet(Thu 10:10AM EDT)
- Q1 2013 Integra LifeSciences Corporation Earnings Release - Before Market OpenCCBN(Thu 7:07AM EDT)
- InPlay: Integra reports Q1 in-line wih April 10 warning; lowers FY13 guidance, in-lineBriefing.com(Thu 6:29AM EDT)
- Integra LifeSciences Reports First Quarter 2013 Financial ResultsGlobeNewswire(Thu 6:00AM EDT)
- Integra Lifesciences Holdings Earnings Preview: Can This Streak Continue?at Wall St. Cheat Sheet(Wed, May 1)
- Integra LifeSciences Introduces Hollywood(TM) VI Spinal Fusion SystemGlobeNewswire(Tue, Apr 30)
- Integra LifeSciences Launches Integra(R) Compact Cranial Closure SystemGlobeNewswire(Mon, Apr 29)
- Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual MeetingGlobeNewswire(Mon, Apr 29)
- 3 Horrendous Health-Care Stocks This Weekat Motley Fool(Fri, Apr 12)
- Product Recall Plagues IntegraZacks(Thu, Apr 11)
- Voluntary Product Recall Sacks Shares of Integra LifeSciencesat Motley Fool(Thu, Apr 11)
- 4 Healthcare Stock Stories for Thursday Investment Wellnessat Wall St. Cheat Sheet(Thu, Apr 11)
- Integra downgraded by Northland CapitalBriefing.com(Thu, Apr 11)
- Integra LifeSciences says evaluating FY13 guidance after voluntary recallat theflyonthewall.com(Wed, Apr 10)
- Integra LifeSciences to Host Its First Quarter 2013 Earnings Results Conference Call on May 2, 2013GlobeNewswire(Wed, Apr 10)
Key Statistics
| Forward P/E (1 yr): | 10.42 |
|---|
| P/S (ttm): | 1.17 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.72 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.45 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.26 |
|---|
Business Summary
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, orthopedics, and general surgery.
View More